Drug intelligence / Profile preview

C-vimin

Development stage
Phase 2
Lead developer
McGuff Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular, Subcutaneous
01

Overview

**C-vimin** is a brand name for a vitamin C (ascorbic acid) supplement used to prevent and treat vitamin C deficiency, including scurvy, and to support wound healing, iron absorption, and immune function. As an essential water-soluble vitamin, it functions as a cofactor in collagen biosynthesis, acts as an antioxidant to neutralize free radicals, and participates in carnitine and neurotransmitter synthesis. It is commonly available in oral forms like tablets and is well-tolerated at recommended doses, with high-dose intravenous use explored for potential benefits in oxidative stress-related conditions like cancer or infections, though evidence varies.

Brand names
C-vimin
Other names
pharmacological ascorbate
02

Targets

P4H (Prolyl 4-hydroxylase subunit alpha-3)

Beyond the preview

Go deeper on C-vimin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-vimin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call